A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Cataract

In brief

This is a safety and efficacy study of a Dexamethasone Drug Delivery System for anterior segment inflammation and pain following cataract extraction with lens implantation.

Key facts

Study ID

NCT01605942

Run by

Allergan

People needed

8

Starts

2012-06-01

Expected to finish

2012-09-01

Last updated by the study team

2015-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Planned single cataract extraction with lens implant
• Best-corrected visual acuity of 20/200 or better in the opposite eye

You may not qualify if…

• Glaucoma or history of intraocular hypertension in the study eye
• History of chronic ocular allergy in the last year requiring treatment
• Scheduled for cataract surgery in the non-study eye during study participation

Where it is running

• Study site — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.